Bio Decontamination Market by Product (Equipment, Services, and Consumables), Agent Type (Hydrogen Peroxide, Chlorine Dioxide, Peracetic Acid, and Nitrogen Dioxide), Type [Chamber Decontamination, Room Decontamination, Facility Decontamination, Equipment Decontamination (Biosafety Cabinets, Isolators, Incubators, Cold Rooms, Walk-In-Chambers, and Others), Routine & Emergency Remediation, and Others] End User (Pharmaceutical & Medical Device Manufacturing Companies, Life Sciences & Biotechnology Research Organizations, and Hospitals & Healthcare Facilities): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026485 | Pages: 100 | Industry: Biotechnology | Date: Sep 2022 | Type: Global

The market crossed US$ 150.52 million mark in 2022 and is expected to hit US$ 242.01 million by 2030, recording a CAGR of 6.1 % during the forecast period. 

Growing demand from pharmaceutical & biotechnology industries for Bio decontamination Equipment

Rising concerns associated with potential cross contamination has aided the adoption of bio contamination equipment by pharmaceutical manufacturers. They usually get addressed by a certified bio-decontamination company and receive validated compliance reports. As of end-2021, the total global pharmaceutical market was valued at about US$ 1.42 trillion. Bio decontamination companies set up deep cleaning, sterilization, and decontamination services for a variety of application/end-users such as pharmaceutical, medical, healthcare and police agencies. Rising pressure to ensure the traceability of pharmaceutical products and maintain pharmaceutical and biotechnology facilities that are free from contamination has aided the overall bio decontamination market growth in the recent past and is expected to continue a similar trend during the forecast period. The failure to maintain good manufacturing practices can lead to life-threatening consequences that may lead to health risks. Thus, to maintain the sterility in pharmaceutical facilities and keep the environment protected from micro-organisms, bio decontamination is considered to be an useful technique which are being used by both pharmaceutical and bio-pharmaceutical companies.

Within the report, the market is segmented into product, agent type, type, end user, and geography. By product, the market is further segmented into equipment, services, and consumables. On the agent type, the market is segmented into hydrogen peroxide, chlorine dioxide, peracetic acid, and nitrogen dioxide. On the type, the market is bifurcated into chamber decontamination, room decontamination, facility decontamination, equipment decontamination, routine & emergency remediation, and others.  Equipment decontamination segment is further segmented into biosafety cabinets, isolators, incubators, cold rooms, walk-in-chambers, and others. Based on end user, the market is segmented pharmaceutical & medical device manufacturing companies, life sciences & biotechnology research organizations, and hospitals & healthcare facilities. Geographically, the market is segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.

Get more information on this report :

Growing healthcare sector and increasing outsourcing in emerging economies is expected to propel the overall market growth

Bio decontamination is gradually favored over other processes because it is cost-efficient and deals with the viral decontamination of products that prevents the spread of bacteria or fungi and the toxic by-products produced by these micro-organisms. The growing developments in the biopharma sector will also branch the industry development. The bio decontamination systems are used for crucial applications in the bio security, life science, experimentation, IVF, food, and pharmaceutical industries. The pharmaceutical and biopharmaceutical companies usually cannot produce to meets the demand for entire consumer profile. They primarily outsource half their services from contract service organizations to meet the demand for the emerging nations such as China, India, and Brazil. During the last decade, businesses in developed markets, such as the US and Europe, have outsourced their manufacturing and packaging operations to China, South Korea, Taiwan, and India owing to less-stringent government regulations prevailing in these countries. As these countries are becoming major manufacturing hubs, there is a greater focus on quality parameters and adopting technologically advanced products to cater to customer requirements. Consequently, the adoption of bio decontamination products & services is growing across many industries in these countries. Such factors is anticipated to propel the overall market growth in the coming years.

Pharmaceutical & medical device manufacturing companies captured the highest share in 2022

The higher incorporation of bio-decontamination products and services in pharmaceutical & medical device manufacturing establishments has led to the adoption in maintaining hygienic and aseptic surroundings that prevents the growth of micro-organisms such as bacteria, virus, and fungi. The influx of technologically advanced products and the ease of access to fleet of decontamination instruments will foster market dynamics. Chamber decontamination is a preferred option used by pharmaceutical & medical device manufacturing organizations as it requires less energy as compared to room decontamination.

Recent strategic developments in bio decontamination market

The bio decontamination market has undergone several significant developments, and a few of these have been mentioned below:

  • In December 2021, TOMI launched the SteraMist Amazon Store featuring SteraPak's which is a disinfection system that can be used by various industries. This expanded the options in distribution channels which aided in optimizing and streamlining the buying process for customers.

 

The bio decontamination market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Steris PLC; Ecolab; TOMI Environmental Solutions, Inc.; JCE Biotechnology; Fedegari Autoclavi SpA; Zhejiang TAILIN Bioengineering Co., LTD; Howorth Air Technology Ltd.; Solidfog Technologies; ClorDiSys Solutions, Inc; Noxilizer, Inc.; Cesstech; AM Instruments srl; Valicare GmbHare among the prominent players operating in the market.

Target audience for the report:

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Life sciences Research Organizations
  • Biotechnology Research Organizations
  • Chemical Companies
  • Food Companies
  • Laboratory Companies
  • Healthcare Service Providers
  • Contract Research Organizations
  • Medical device manufacturers

Scope of the report:

In this report, the market has been segmented on the basis of:

Product

  • Equipment
  • Services
  • Consumables
  • Agent Type
  • Hydrogen Peroxide
  • Chlorine Dioxide
  • Peracetic Acid
  • Nitrogen Dioxide

Type

  • Chamber Decontamination
  • Room Decontamination
  • Facility Decontamination
  • Equipment Decontamination
    • Biosafety Cabinets
    • Isolators
    • Incubators
    • Cold Rooms
    • Walk in Chambers
    • Others
  • Routine and Emergency Remediation
  • Others

End User

  • Pharmaceutical & Medical Device Manufacturing Companies
  • Life Sciences & Biotechnology Research Organizations
  • Hospitals & Healthcare Facilities

Region

    • North America
      • US
      • Canada
      • Mexico
    • Europe
    • Asia Pacific (APAC)
    • Middle East & Africa
    • South & Central America

Companies profiled:

    • Steris PLC
    • Ecolab
    • TOMI Environmental Solutions, Inc.
    • JCE Biotechnology
    • Fedegari Autoclavi SpA
    • Zhejiang TAILIN Bioengineering Co., LTD
    • Howorth Air Technology Ltd
    • Solidfog Technologies
    • ClorDiSys Solutions, Inc
    • Noxilizer, Inc.
    • Cesstech
    • AM Instruments Srl 
    • Valicare GmbH
    • Other market participants

Companies profiled:
- Steris PLC
- Ecolab
- TOMI Environmental Solutions, Inc.
- JCE Biotechnology
- Fedegari Autoclavi SpA
- Zhejiang TAILIN Bioengineering Co., LTD
- Howorth Air Technology Ltd
- Solidfog Technologies
- ClorDiSys Solutions, Inc
- Noxilizer, Inc.
- Cesstech
- AM Instruments Srl
- Valicare GmbH
- Other market participants

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$2000
Site License
$3000
Enterprise License
$4000